Controlled coupling of an ultrapotent auristatin warhead to...

  • Main
  • 2020 / 09
  • Controlled coupling of an ultrapotent auristatin warhead to...

Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer

Greene, Michelle K., Chen, Ting, Robinson, Eifion, Straubinger, Ninfa L., Minx, Charlene, Chan, Darren K. W., Wang, Jun, Burrows, James F., Van Schaeybroeck, Sandra, Baker, James R., Caddick, Stephen,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-020-01046-6
Date:
September, 2020
File:
PDF, 1.75 MB
2020
Conversion to is in progress
Conversion to is failed